Back
Amplify Digital Payments ETF Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
89
IPAY
Amplify Digital Payments ETF
Last Price:
58.65
Seasonality Move:
4.83%
Sell
39
HALO
Halozyme Therapeutics
Last Price:
45.65
Seasonality Move:
17.03%
Buy
89
Amplify Digital Payments ETF (IPAY)
is a Buy
Is Amplify Digital Payments ETF a Buy, Sell or Hold?
- The current Amplify Digital Payments ETF [IPAY] share price is $58.58. The Score for IPAY is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- IPAY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPAY Stock Price Chart
What is Amplify Digital Payments ETF's stock price today?
-
The Amplify Digital Payments ETF share price today is $58.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPAY is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
IPAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.61 | Buy |
Relative Strength Index (14 RSI): | 67.59 | Buy |
Chaikin Money Flow: | 59937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.27 - 57.63) | Buy |
Bollinger Bands (100): | (47.73 - 54.35) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 30.2 | Sell |
Chaikin Money Flow: | -7140517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.94 - 58.56) | Sell |
Bollinger Bands (100): | (52.16 - 60.38) | Sell |
IPAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.45 | Buy |
20-day SMA: | 55.69 | Buy |
50-day SMA: | 53.59 | Buy |
200-day SMA: | 49.99 | Buy |
8-day EMA: | 58 | Buy |
20-day EMA: | 56.31 | Buy |
50-day EMA: | 54.05 | Buy |
200-day EMA: | 49.91 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.53 | Sell |
20-day SMA: | 54.48 | Sell |
50-day SMA: | 56.18 | Sell |
200-day SMA: | 48.93 | Sell |
8-day EMA: | 55 | Sell |
20-day EMA: | 55.41 | Sell |
50-day EMA: | 55.64 | Sell |
200-day EMA: | 50.73 | Sell |
Amplify Digital Payments ETF Earnings Growth & IPAY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.
Amplify Digital Payments ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |